Latest News

January 24, 2020
The Institute for Clinical and Economic Review (ICER) published a draft evidence report on crizanlizumab (Adakveo), voxelotor (Oxbryta), and L-glutamine (Endari) for sickle cell disease, as well as a draft scoping document on valoctocogene roxaparvovec, an investigational gene therapy, and emicizumab (Helimbra) for hemophilia.
 
January 24, 2020
Amid the disappointment that the Camden Coalition's "hot spotting" efforts did not reduce hospital readmissions, we note how a well-read 2007 paper in our archives showed that expenditures on disease management do not always produce a return on investment.
January 24, 2020
Shifting towards an anti-inflammatory and suppressive homeostatic immune system may contribute to increased clinical efficacy of siponimod in patients with secondary progressive multiple sclerosis (SPMS), a recent study in JCI Insight reported.
 
January 24, 2020
This week, the top managed care stories included a case involving health coverage for birth control reaching the Supreme Court; polls on healthcare anger President Trump; a popular diabetes drug receives a new indication.
 
January 24, 2020
Balance training of moderate intensity (BT) may increase anti-inflammatory cytokines and neurotrophic factor levels of patients with Parkinson disease (PD), according to study findings.
January 24, 2020
A formulation of calcipotriene and betamethasone dipropionate cream met its primary endpoint for treating plaque psoriasis during its phase 3 trial in the European Union, according to an announcement from MC2 Therapeutics.
January 24, 2020
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
January 24, 2020
A pharmaceutical company executive is sentenced for his role in the opioid crisis; the CDC confirms the second US case of the Chinese coronavirus; the FDA issues accelerated approval of Tazverik for epithelioid sarcoma.
 
January 23, 2020
The US Surgeon General, Jerome M. Adams, MD, MPH, has released the first report since 1990 that focuses solely on smoking cessation in America. Smoking accounts for the deaths of half a million Americans each year and is the leading cause of preventable disease, disability, and death in the country.
 
Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.